Athens Medical C.S.A. (ATH:IATR)
Greece · Delayed Price · Currency is EUR 1.590
+0.010 (0.63%)
Sep 2, 2026, 5:08 PM EET
Athens Medical C.S.A. Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 138 | 172 | 131 | 160 | 123 | 147 | |
Market Cap Growth | -29.65% | 31.56% | -18.43% | 29.93% | -15.98% | 10.82% |
Enterprise Value | 289 | 311 | 257 | 294 | 240 | 245 |
Last Close Price | 1.59 | 1.98 | 1.50 | 1.82 | 1.38 | 1.57 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 73.38 | 19.80 | 17.99 | 9.74 |
PS Ratio | 0.50 | 0.62 | 0.48 | 0.62 | 0.53 | 0.65 |
PB Ratio | 1.33 | 1.65 | 1.20 | 1.47 | 1.19 | 1.44 |
P/TBV Ratio | 1.43 | 1.78 | 1.27 | 1.51 | 1.21 | 1.45 |
P/FCF Ratio | - | - | 6.59 | 42.35 | - | 32.83 |
P/OCF Ratio | 27.10 | 33.75 | 2.81 | 6.13 | 993.27 | 9.31 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.05 | 1.13 | 0.95 | 1.14 | 1.03 | 1.09 |
EV/EBITDA Ratio | 11.43 | 15.81 | 9.97 | 8.96 | 8.67 | 7.80 |
EV/EBIT Ratio | 36.90 | 39.76 | 17.18 | 12.87 | 13.12 | 10.80 |
EV/FCF Ratio | - | - | 12.97 | 77.91 | - | 54.96 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.75 | 1.75 | 1.35 | 1.46 | 1.40 | 1.48 |
Debt / EBITDA Ratio | 7.22 | 7.22 | 4.73 | 4.26 | 4.57 | 4.28 |
Debt / FCF Ratio | - | - | 7.43 | 41.95 | - | 33.74 |
Net Debt / Equity Ratio | 1.45 | 1.45 | 1.19 | 1.25 | 1.23 | 0.97 |
Net Debt / EBITDA Ratio | 7.66 | 7.66 | 5.03 | 4.16 | 4.61 | 3.13 |
Net Debt / FCF Ratio | -12.75 | -12.75 | 6.55 | 36.13 | -8.09 | 22.10 |
Asset Turnover | 0.54 | 0.54 | 0.56 | 0.58 | 0.56 | 0.54 |
Inventory Turnover | 29.21 | 29.21 | 29.55 | 27.51 | 25.22 | 24.23 |
Quick Ratio | 0.68 | 0.68 | 0.73 | 0.90 | 0.99 | 1.08 |
Current Ratio | 0.76 | 0.76 | 0.83 | 0.98 | 1.10 | 1.21 |
Return on Equity (ROE) | -4.34% | -4.34% | 1.73% | 7.70% | 6.74% | 12.74% |
Return on Assets (ROA) | 0.95% | 0.95% | 1.92% | 3.19% | 2.74% | 3.40% |
Return on Invested Capital (ROIC) | 3.07% | 3.17% | 2.59% | 5.72% | 5.47% | 9.13% |
Return on Capital Employed (ROCE) | 3.20% | 3.20% | 5.60% | 8.30% | 6.70% | 8.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -3.39% | -2.72% | 1.36% | 5.05% | 5.56% | 10.27% |
FCF Yield | -8.58% | -6.89% | 15.18% | 2.36% | -12.79% | 3.05% |
Dividend Yield | - | - | - | 1.10% | - | 4.46% |
Payout Ratio | - | - | 97.13% | - | - | 0.54% |
Total Shareholder Return | - | - | - | 1.10% | - | 4.46% |